Close Menu

NEW YORK ─ Luminex on Wednesday announced preliminary financial results for the second quarter of 2020, saying it anticipates revenues would increase more than 30 percent over Q2 2019, driven by pandemic-related sales across all respiratory and COVID-19 products.

For the three months ended June 30, the molecular diagnostics firm said its revenues would be between $109 million and $110 million compared to the $83.1 million that it reported for the prior-year quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.